Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Serum fructosamine and subsequent breast cancer risk: a nested case-control study in the ORDET prospective cohort study.

Platek M, Krogh V, Micheli A, Browne R, Meneghini E, Sieri S, Sch√ľnemann HJ, Pala V, Barba M, Wilding GE, Berrino F, Muti P. Serum fructosamine and subsequent breast cancer risk: a nested case-control study in the ORDET prospective cohort study. Cancer Epidemiol Biomarkers Prev. 2005 Jan; 14(1):271-4.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.